pulmonary embolism

This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.

Benefits of AZ COVID-19 vaccine 'continue' to outweigh risks, says EMA’s executive director

of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia was discovered.

Safety review shows ‘no evidence’ that AZ's vaccine causes increased risk of blood clots

In a review of all available safety data from over 17 million people vaccinated with the AZ vaccine in the EU and UK, no evidence of an increased risk of pulmonary ... The company added that, as of 8 March, it has received reports of 15 DVT events and 22
Dear Joe

You are no stranger to the importance of individual health. You suffer from asthma and have undergone two surgeries for intracranial aneurysms and a pulmonary embolism.
FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

The FDA has approved Micro Labs and Mylan’s generics to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), one of Eliquis’ key indications. ... BMS and Pfizer’s drug is also used to prevent deep
Zafgen shares tumble after FDA places hold on diabetes trial

This was abandoned in 2016 after two patients died in a phase 3 trial of the drug after suffering a pulmonary embolism.
Boston Scientific makes $4.2bn play for UK’s BTG

Boston Scientific’s chief executive Michael Mahoney highlighted BTG’s cancer and pulmonary embolism portfolios – which include products to freeze and deliver radiotherapy or drugs to tumours and devices to dissolve

More from news
Approximately 2 fully matching, plus 50 partially matching documents found.

Modern anticoagulants threaten status quo

embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Add my company

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

InSite Events™ National Pharma Meeting: A Customer Story: How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?: The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19: The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...